CCM
SANA icon

Coldstream Capital Management’s Sana Biotechnology SANA Stock Holding History

Coldstream Capital Management’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Sell
45,000
-1
-0% -$3 ﹤0.01% 1185
2026
Q1 		$130K Buy
+45,001
New +$177K ﹤0.01% 1152
2025
Q2 		– Sell
-1,360
Closed -$2.29K – 2920
2025
Q1 		$2.29K Sell
1,360
-33,812
-96% -$94.5K ﹤0.01% 2957
2024
Q4 		$57.3K Buy
+35,172
New +$105K ﹤0.01% 1057

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Coldstream Capital Management's SANA Position: Q2 2026 in Review

Coldstream Capital Management reduced its Sana Biotechnology (SANA) stake by 0% in Q2 2026, selling an estimated $3 and leaving 45,000 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #1185.

Coldstream Capital Management first reported a position in SANA in Q4 2024 and has held it in 4 quarters since. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Coldstream Capital Management held 45,000 shares of Sana Biotechnology worth $157K as of Q2 2026.
  • Coldstream Capital Management sold 1 Sana Biotechnology share in Q2 2026, an estimated $3.
  • Sana Biotechnology made up ﹤0.01% of Coldstream Capital Management's portfolio in Q2 2026, its #1185 holding.
  • Coldstream Capital Management first reported a position in Sana Biotechnology in Q4 2024 and has held it in 4 quarters since.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Coldstream Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.